Skip to search formSkip to main contentSkip to account menu

Barrett's Adenocarcinoma

Known as: Adenocarcinoma Arising in Barrett's Mucosa, Barrett Adenocarcinoma 
An adenocarcinoma arising from Barrett metaplastic epithelium in the esophagus. There is evidence supporting the idea that the Barrett… 
National Institutes of Health

Related topics

Related topics

19 relations
Barrett EsophagusDeglutition DisordersEGFR Gene AmplificationERBB2 Gene Amplification

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Increased expression of the 5‐lipoxygenase pathway and its cellular localization in Barrett’s adenocarcinoma
Boger P C, Shutt J D, Neale J R, Wilson S J, Bateman A C, Holloway J W, Patel P & Sampson A P 
(2012) Histopathology 61, 509–517 
2010
2010
Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy.
Highly Cited
2005
Highly Cited
2005
Association of Pretherapeutic Expression of Chemotherapy-Related Genes with Response to Neoadjuvant Chemotherapy in Barrett Carcinoma
Purpose: We analyzed pretherapeutic gene expression patterns of patients with locally advanced adenocarcinomas of the esophagus… 
Review
2005
Review
2005
Is adenocarcinoma of the esophagogastric junction or cardia different from Barrett adenocarcinoma?
Over time the relative distribution of cancers of the proximal digestive tract has changed. Squamous cell carcinomas of the… 
2004
2004
Gene amplification and overexpression in gastric adenocarcinoma and barrett adenocarcinoma
2003
2003
Ligand for peroxisome proliferator-activated receptor-Γ inhibits proliferation and induces apoptosis of barrett's adenocarcinoma both in vitro and in vivo
Review
2003
Review
2003
Report of an Amsterdam Working Group on Barrett Esophagus
More than 50 years have passed since Barrett described a case of peptic ulcer disease of the esophagus and the condition that… 
2001
2001
Evidence for a molecular biomarker of malignant potential specific to Barrett's adenocarcinoma on the p arm of chromosome 17
Highly Cited
2001
Highly Cited
2001
Exclusive radical surgery for esophageal adenocarcinoma
Because very poor survival rates were reported after exclusive nonradical surgery, the current opinion in the medical community… 
2000
2000
The evolution of loss of heterozygosity on chromosome 17 during the progression to barrett's adenocarcinoma involves a unique combination of target sites in individual specimens.
We have previously identified thirteen common minimally deleted regions (MRs) on chromosome 17 in twelve Barrett's esophageal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)